# Clinical Study of Hepatocyte Transplantation for Liver Cirrhosis

> **NCT04806581** · PHASE1 · UNKNOWN · sponsor: **RenJi Hospital** · enrollment: 20 (estimated)

## Conditions studied

- Liver Cirrhosis

## Interventions

- **DRUG:** Allogeneic Hepatocyte

## Key facts

- **NCT ID:** NCT04806581
- **Lead sponsor:** RenJi Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-04-20
- **Primary completion:** 2024-12-31
- **Final completion:** 2025-03-31
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2021-03-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04806581

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04806581, "Clinical Study of Hepatocyte Transplantation for Liver Cirrhosis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04806581. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*